Lopressor patient counseling information: Difference between revisions

Jump to navigation Jump to search
GeraldChi (talk | contribs)
No edit summary
GeraldChi (talk | contribs)
No edit summary
Line 5: Line 5:
===Information for Patients===
===Information for Patients===


* Take Lopressor regularly and continuously, as directed, with or immediately following meals.
Take Lopressor regularly and continuously, as directed, with or immediately following meals.


* If a dose should be missed, the patient should take only the next scheduled dose (without doubling it).
If a dose should be missed, the patient should take only the next scheduled dose (without doubling it).


* Patients should not discontinue Lopressor without consulting the physician.
Patients should not discontinue Lopressor without consulting the physician.


* Avoid operating automobiles and machinery or engaging in other tasks requiring alertness until the patient’s response to therapy with Lopressor has been determined.
Avoid operating automobiles and machinery or engaging in other tasks requiring alertness until the patient’s response to therapy with Lopressor has been determined.


* Contact the physician if any difficulty in breathing occurs.
Contact the physician if any difficulty in breathing occurs.


* Inform the physician or dentist before any type of surgery that he or she is taking Lopressor.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = LOPRESSOR (METOPROLOL TARTRATE) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb05420c-fd24-4672-9f62-fdd313819287 | publisher =  | date =  | accessdate = }}</ref>
Inform the physician or dentist before any type of surgery that he or she is taking Lopressor.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = LOPRESSOR (METOPROLOL TARTRATE) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION] | url =http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=bb05420c-fd24-4672-9f62-fdd313819287 | publisher =  | date =  | accessdate = }}</ref>


==References==
==References==
Line 23: Line 23:
{{FDA}}
{{FDA}}


[[Category:Antianginals]]
[[Category:Antiarrhythmic agents]]
[[Category:Antihypertensive agents]]
[[Category:Antimigraine drugs]]
[[Category:Beta blockers]]
[[Category:Beta blockers]]
[[Category:Cardiovascular Drugs]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]

Revision as of 00:51, 14 March 2014

Metoprolol
Clinical data
Trade namesLopressor, Toprol-xl
AHFS/Drugs.comMonograph
MedlinePlusa682864
[[Regulation of therapeutic goods |Template:Engvar data]]
Pregnancy
category
  • AU: C
  • US: C (Risk not ruled out)
Routes of
administration
Oral, IV
ATC code
Legal status
Legal status
  • In general: ℞ (Prescription only)
Pharmacokinetic data
Bioavailability12%
MetabolismHepatic via CYP2D6, CYP3A4
Elimination half-life3-7 hours
ExcretionRenal
Identifiers
CAS Number
PubChem CID
IUPHAR/BPS
DrugBank
ChemSpider
UNII
KEGG
ChEBI
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC15H25NO3
Molar mass267.364 g/mol
3D model (JSmol)
Melting point120 °C (248 °F)
  (verify)

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, M.D. [2]

Information for Patients

Take Lopressor regularly and continuously, as directed, with or immediately following meals.

If a dose should be missed, the patient should take only the next scheduled dose (without doubling it).

Patients should not discontinue Lopressor without consulting the physician.

Avoid operating automobiles and machinery or engaging in other tasks requiring alertness until the patient’s response to therapy with Lopressor has been determined.

Contact the physician if any difficulty in breathing occurs.

Inform the physician or dentist before any type of surgery that he or she is taking Lopressor.[1]

References

  1. "LOPRESSOR (METOPROLOL TARTRATE) TABLET [NOVARTIS PHARMACEUTICALS CORPORATION]".

Adapted from the FDA Package Insert.